{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20260311",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85360",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217159s009lbl.pdf",
              "date": "20260312",
              "type": "Label"
            },
            {
              "id": "85368",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/217159Orig1s009ltr.pdf",
              "date": "20260312",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230908",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75390",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217159Orig1s000ltr.pdf",
              "date": "20230911",
              "type": "Letter"
            },
            {
              "id": "75441",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217159s000lbl.pdf",
              "date": "20230913",
              "type": "Label"
            },
            {
              "id": "75522",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/217159Orig1s000TOC.html",
              "date": "20230921",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA217159",
      "sponsor_name": "AYRMID PHARMA",
      "openfda": {
        "application_number": [
          "NDA217159"
        ],
        "brand_name": [
          "APHEXDA"
        ],
        "generic_name": [
          "MOTIXAFORTIDE"
        ],
        "manufacturer_name": [
          "Gamida Cell Inc.",
          "BioLineRx USA Inc"
        ],
        "product_ndc": [
          "73441-062",
          "82737-073"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "MOTIXAFORTIDE ACETATE"
        ],
        "rxcui": [
          "2664901",
          "2664906"
        ],
        "spl_id": [
          "876ecb7b-a6d5-442b-a5a1-4e24203853cc",
          "241b0b4f-eca3-be93-e063-6394a90a5789"
        ],
        "spl_set_id": [
          "e704b2db-f119-40ba-9346-9229e3281c9e",
          "f7cdc584-ebf0-a68e-e053-6294a90a9ea9"
        ],
        "package_ndc": [
          "73441-062-01",
          "82737-073-01"
        ],
        "unii": [
          "3ZPX60DV8A"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "APHEXDA",
          "active_ingredients": [
            {
              "name": "MOTIXAFORTIDE ACETATE",
              "strength": "EQ 62MG BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}